Acorda Therapeutics
ACOR
$0.66
Share price
0.00%
Change (1 day)
40.64%
Change (1 year)
Categories
Market capitalization of Acorda Therapeutics (ACOR)
Market cap: $0.82 Million
As of April 2024 Acorda Therapeutics has a market cap of $0.82 Million. This makes Acorda Therapeutics the world's 8352th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.
Market cap history of Acorda Therapeutics from 2006 to 2024
End of year Market Cap
| Year | Market cap | Change |
|---|---|---|
| 2024 | $0.82 M | -95.62% |
| 2023 | $18.74 M | 0.45% |
| 2022 | $18.65 M | -30.3% |
| 2021 | $26.77 M | -31.78% |
| 2020 | $39.24 M | -59.67% |
| 2019 | $97.31 M | -86.83% |
| 2018 | $0.73 B | -26.32% |
| 2017 | $1.00 B | 15.66% |
| 2016 | $0.86 B | -52.86% |
| 2015 | $1.83 B | 7.46% |
| 2014 | $1.71 B | 43.35% |
| 2013 | $1.19 B | 20.68% |
| 2012 | $0.98 B | 4.61% |
| 2011 | $0.94 B | -10.51% |
| 2010 | $1.05 B | 10.55% |
| 2009 | $0.95 B | 23.58% |
| 2008 | $0.77 B | 23.27% |
| 2007 | $0.62 B | 67.45% |
| 2006 | $0.37 B |
End of Day market cap according to different sources
On Apr 24th, 2024 the market cap of Acorda Therapeutics was reported to be:
Market capitalization for similar companies or competitors
| Name | Market cap | Market cap differencediff. | Country |
|---|---|---|---|
 Sarepta Therapeutics
SRPT | $11.95 B | 1,456,152.33% | 🇺🇸 USA |
 Repligen
RGEN | $9.25 B | 1,126,561.42% | 🇺🇸 USA |
 Affimed
AFMD | $74.31 M | 8,950.87% | 🇩🇪 Germany |
 BioMarin Pharmaceutical BMRN | $15.59 B | 1,899,203.31% | 🇺🇸 USA |